Average out-of-pocket costs associated with rebates were highest for uninsured patients ($39), followed by Medicare patients ($13), and then those with commercial insurance ($6). (Photo: Shutterstock)
Drug rebates for insurers often are associated with increases in out-of-pocket costs for patients, according to a new University of Washington study that examined cost and price data on more than 400 branded drugs.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.